Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · IEX Real-Time Price · USD
16.70
+0.76 (4.77%)
Apr 26, 2024, 12:36 PM EDT - Market open
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for EWTX stock have an average target of 31.2, with a low estimate of 25 and a high estimate of 48. The average target predicts an increase of 86.83% from the current stock price of 16.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EWTX stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 3 | 3 | 3 | 4 | 4 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Maintains $28 → $32 | Buy | Maintains | $28 → $32 | +91.62% | Apr 22, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +49.70% | Apr 17, 2024 |
Wedbush | Wedbush | Buy Reiterates $26 | Buy | Reiterates | $26 | +55.69% | Apr 16, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $28 | Buy | Reiterates | $28 | +67.66% | Mar 12, 2024 |
Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +187.43% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.75
from -1.57
EPS Next Year
-2.09
from -1.75
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 26.3M | 416.5M | 899.6M |
Avg | n/a | n/a | 12.8M | 193.8M | 578.1M |
Low | n/a | n/a | n/a | 67.9M | 269.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 3,166.7% | 364.2% |
Avg | - | - | - | 1,419.8% | 198.3% |
Low | - | - | - | 432.5% | 39.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.31 | -1.75 | -2.34 | -1.94 | 3.58 |
Avg | -1.75 | -2.09 | -2.51 | -1.96 | 2.52 |
Low | -2.30 | -2.45 | -2.83 | -1.96 | 1.51 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.